Prevalence

Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023: Rising Prevalence of Zoonotic Diseases Fuels Demand - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 25, 2023
Veterinary, Health, Human, Diagnosis, Prevalence, Infection, Zoonosis, World Health Organization, USD, Sale, Organization, Animal, Acquisition, BioMérieux, Algorithm, Growth, AST, Geography, Vaccine

The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • Technological advancements have emerged as a key trend gaining popularity in the veterinary antimicrobial susceptibility testing market.
  • The rising prevalence of zoonotic diseases is expected to propel the growth of the veterinary antimicrobial susceptibility testing market going forward.
  • Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary antimicrobial susceptibility testing market.

Global Edge AI Hardware Market 2023-2032: Rise in Investments in AI Startups & Increase in Demand for Smart Homes & Smart Cities Creates Opportunities

Retrieved on: 
Tuesday, July 25, 2023
Human, Qualcomm, Samsung Electronics, Prevalence, Big data, Electronics, Internet of things, Apple Inc., Vertical, Intelligence, USD, NLP, Internet, Device, Huawei, Consumer, Growth, Processor, Function, Medical device, Video game

The global edge AI hardware market size is expected to reach USD 7,977.31 million by 2032.

Key Points: 
  • The global edge AI hardware market size is expected to reach USD 7,977.31 million by 2032.
  • Additionally, the market is expected to experience further growth due to the growing use of edge AI hardware for robust analytics, the trend of compressing large AI models into smaller hardware forms, and the substantial increase in government funding.
  • An example of this growth can be seen in the recent unveiling of Perceive AI's new Edge AI Chip named Ergo2 in January 2023.
  • To effectively tap into the growing potential of big data, there is a need to push artificial intelligence to the network edge.

Shutterstock Joins the Content Authenticity Initiative

Retrieved on: 
Tuesday, July 25, 2023
CAI, Enterprise, Metadata, Partnership, United Nations, Shutterstock, Meta, Prevalence, Data science, Marketing, 3D, C2PA, Author, OpenAI, IP, Organization, ITU, Trust, NVIDIA, Adobe, Artificial intelligence, Content Authenticity Initiative, LG, United, Ecosystem, AI, NYSE, Education, Medical device

NEW YORK, July 25, 2023 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform offering high-quality content and full-service creative workflow solutions for transformative brands, digital media and marketing companies, today announced its participation in the Content Authenticity Initiative (CAI). Through its participation, Shutterstock will support the CAI's goal of addressing the prevalence of misleading information online through the implementation of technical standards for certifying the source and history of media content by integrating Content Credentials.

Key Points: 
  • (NYSE: SSTK), a leading global creative platform offering high-quality content and full-service creative workflow solutions for transformative brands, digital media and marketing companies, today announced its participation in the Content Authenticity Initiative (CAI) .
  • Through its participation, Shutterstock will support the CAI's goal of addressing the prevalence of misleading information online through the implementation of technical standards for certifying the source and history of media content by integrating Content Credentials.
  • Shutterstock intends to integrate the underlying Coalition for Content Provenance and Authenticity (C2PA) standard into its AI capabilities and various creativity tools, including its DALL·E-powered AI Image Generator and suite of AI-powered applications to further protect its users with verifiable and tamper-evident information across all forms of content.
  • With Content Credentials, this will include ensuring each asset is certified with secure metadata about its creation, authorship and edit history.

Shutterstock Joins the Content Authenticity Initiative

Retrieved on: 
Tuesday, July 25, 2023
CAI, Enterprise, Metadata, Partnership, United Nations, Shutterstock, Meta, Prevalence, Data science, Marketing, 3D, C2PA, Author, OpenAI, IP, Organization, ITU, Trust, NVIDIA, Adobe, Artificial intelligence, Content Authenticity Initiative, LG, United, Ecosystem, AI, NYSE, Education, Medical device

NEW YORK, July 25, 2023 /PRNewswire/ -- Shutterstock, Inc. (NYSE: SSTK), a leading global creative platform offering high-quality content and full-service creative workflow solutions for transformative brands, digital media and marketing companies, today announced its participation in the Content Authenticity Initiative (CAI). Through its participation, Shutterstock will support the CAI's goal of addressing the prevalence of misleading information online through the implementation of technical standards for certifying the source and history of media content by integrating Content Credentials.

Key Points: 
  • (NYSE: SSTK), a leading global creative platform offering high-quality content and full-service creative workflow solutions for transformative brands, digital media and marketing companies, today announced its participation in the Content Authenticity Initiative (CAI) .
  • Through its participation, Shutterstock will support the CAI's goal of addressing the prevalence of misleading information online through the implementation of technical standards for certifying the source and history of media content by integrating Content Credentials.
  • Shutterstock intends to integrate the underlying Coalition for Content Provenance and Authenticity (C2PA) standard into its AI capabilities and various creativity tools, including its DALL·E-powered AI Image Generator and suite of AI-powered applications to further protect its users with verifiable and tamper-evident information across all forms of content.
  • With Content Credentials, this will include ensuring each asset is certified with secure metadata about its creation, authorship and edit history.

Global Skin Tightening Products Market Report 2023: Neutrogena, Olay, SkinCeuticals, The Ordinary, and More Companies Featured - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 25, 2023
Cosmetics, Retail, Hydroxyproline, Tsubaki, Prevalence, Face, Serum, Moisturizer, Woman, Amazon (company), Hyaluronic acid, UV, Skin

As a result, people are seeking products like moisturizers for their skincare routines in order to maintain good skin health and avoid premature skin aging.

Key Points: 
  • As a result, people are seeking products like moisturizers for their skincare routines in order to maintain good skin health and avoid premature skin aging.
  • Shopping for skin tightening products through online distribution channel such as Amazon.com, Inc., Nykaa E-Retail Pvt.
  • The presence of various leading market players in the region is a major factor contributing to the market growth.
  • Additionally, it contains squalane for moisturization, rose wax for skin protection, shea butter, and tsubaki seed oil to hydrate and nourish the lips

Propanc Biopharma’s Clinical Candidate PRP Targeting Pancreatic Cancer Market Forecast to Reach $6.93 Billion by 2030

Retrieved on: 
Tuesday, July 25, 2023
Research, General Health, Pharmaceutical, Oncology, Hospitals, Genetics, Clinical Trials, Science, Surgery, Biotechnology, FDA, Health, Vaccine, Molecular biology, OTC Markets Group, PPCB, Pancreatic cancer, ODE, Orphan Drug Act of 1983, US Foods, Prevalence, MB, Skin, Lymphatic system, Survival, Breast, Brain, Tobacco, Prostate, Life expectancy, Lung, Incidence, ODA, US, Bachelor of Medicine, Bachelor of Surgery, PRP, MD, Patient, Chymotrypsinogen, Trypsinogen, Kidney, Liver, Growth, R, Food, Disease, Pharmaceutical industry

Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s clinical candidate PRP targeting the pancreatic cancer market is forecast to reach $6.93 Billion by 2030, according to a report published by The Brainy Insights, a market research company.

Key Points: 
  • Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s clinical candidate PRP targeting the pancreatic cancer market is forecast to reach $6.93 Billion by 2030, according to a report published by The Brainy Insights, a market research company.
  • According to the report, the global pancreatic cancer market is expected to grow at a compound annual growth rate (CAGR) of 8.13% during the forecast period between 2022 to 2030.
  • As a result of laboratory and clinical studies undertaken in pancreatic cancer, Propanc applied for and received Orphan Drug Designation from the US FDA for the use of PRP to treat pancreatic cancer.
  • Orphan Drug Designation status of PRP has been granted from the US Food and Drug Administration (FDA) for treatment of pancreatic cancer.

Respiratory Devices Global Market - Forecast to 2029 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 25, 2023
Medical Devices, Health, COPD, Humidifier, Prevalence, Hospital, Research, Government, Asthma, Center for Urban and Regional Analysis, Incidence, Nebulizer, PAP, Growth, Video game, Medical device, CO-oximeter

The "Respiratory Devices Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Respiratory Devices Global Market - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The respiratory care devices global market is estimated is expected to grow at a mid single digit CAGR from 2022 to 2029 to reach $24,866.6 million by 2029.
  • Technological advancements in respiratory care devices and funding for the development of innovative respiratory technologies further boost the growth of market.
  • Whereas rising use of non - invasive respiratory care devices, advancements in respiratory care devices, funding for the development of innovative respiratory care technologies and favorable reimbursement are providing immense opportunities to the market.

UnitedHealthcare Donates $1.5 Million To Six Nonprofit Organizations in Georgia

Retrieved on: 
Tuesday, July 25, 2023
Mental Health, Hospitals, Fitness & Nutrition, Health Insurance, Philanthropy, Managed Care, Health, General Health, Other Philanthropy, American Journal of Preventive Medicine, Obesity, Food, Housing, Prevalence, Diabetes, Health education, National Healthy Mothers, Healthy Babies Coalition, Health equity, Preventive healthcare, Supplemental Nutrition Assistance Program, American Medical Association, NYSE, UNH, American Journal, Social isolation, Optum, Transport, Health literacy, Lower Coastal Plain (Georgia), Nursing, Pharmaceutical industry, Toy, UnitedHealth Group

In total, UnitedHealthcare is donating more than $11.1 million in grants through its Empowering Health program across 12 states.

Key Points: 
  • In total, UnitedHealthcare is donating more than $11.1 million in grants through its Empowering Health program across 12 states.
  • America’s Second Harvest of Coastal Georgia – $180,000 to purchase healthy shelf-stable foods for the Mobile Food Pantry, which serves 21 rural counties in the coastal Georgia region.
  • “UnitedHealthcare is honored to support the important work these local organizations are doing to provide greater access to services for underserved communities in Georgia,” said Michael Minor, CEO, UnitedHealthcare Community Plan of Georgia.
  • Since launching its Empowering Health commitment in 2018, UnitedHealthcare has now invested more than $62 million in Empowering Health grants, reaching nearly 11 million people through partnerships with community-based organizations in 30 states and the District of Columbia.

CHOP Researchers Validate Pediatric "Allergic March" in Largest National Study of its Kind

Retrieved on: 
Tuesday, July 25, 2023
Shellfish, Allergy, Asthma, Eosinophilic esophagitis, Consortium, Prevalence, CHOP, Food allergy, Dermatitis, CER2, Food, Quality of life, Allergic rhinitis, Philadelphia, Atopic dermatitis, Risk, Doctor of Philosophy, EHR, Patient, Division, DOI, Diagnosis, Hospital, Immunology, Research, Comparative effectiveness research, Immunoglobulin E, Bias, Health information management, Peanut, Disease, Children's Hospital of Philadelphia, Nursing, Dentistry, Vaccine, Cochineal, Pediatrics, Child, MD, White

PHILADELPHIA, July 25, 2023 /PRNewswire/ -- In the largest study of its kind, researchers from Children's Hospital of Philadelphia (CHOP) used electronic health record (EHR) data from more than 200,000 pediatric patients to describe patterns of pediatric allergies across the United States, validating a population-level pattern of allergy development known as the "allergic march," in which allergies first present as eczema, followed by food allergies, asthma, and environmental allergies. The researchers also found that a rare food allergy called eosinophilic esophagitis (EoE), which has historically been considered a disease affecting primarily White males, is more common among non-White patients than previously reported.

Key Points: 
  • "Prior studies have gauged the prevalence and patterns of allergies based on surveys completed by families.
  • For each condition, they determined the age at diagnosis and whether and when patients presented with other allergic conditions.
  • The researchers examined demographic trends to examine non-biologic factors that may affect predisposition to allergy.
  • "Patterns of pediatric allergy across a multi-state electronic health record consortium," Pediatrics, July 25, 2023, DOI: 10.1542/peds.2022-060531

National Minority Quality Forum Urges Policymakers to Ensure Equitable Access to New Respiratory Syncytial Virus Immunizations

Retrieved on: 
Monday, July 24, 2023
Vaccine, ACIP, Infection, Poverty, Infant, Prevalence, Hospital, Parent, Advisory Committee, Health equity, Vaccines for Children Program, Black, Respiratory syncytial virus, Death, VFC, RSV, Risk, Advisory Committee on Immunization Practices, Diagnosis, Letter, Immunization, Pharmaceutical industry, Publishing, Medicaid, Sanofi

Health Equity Action Report shows low-income children of color are at high risk of severe RSV

Key Points: 
  • It is a highly contagious respiratory virus that can result in severe illness, hospitalizations, and in some cases, even death.
  • "RSV is a growing concern for families of young children across the country and like so many other diseases and illnesses, it disproportionately affects minoritized communities," said Dr. Gary Puckrein, President and CEO of National Minority Quality Forum.
  • We feel very strongly that our policymakers should ensure that any future immunizations should be available for free to all families to help reduce disparities."
  • The disparities are a culmination of inadequate health insurance coverage, access to primary care, and lack of culturally competent care.